Form 4: SI-BONE CEO Laura Francis Files Form 4 for Planned Stock Sale and Trust Transfer

SI-BONE, Inc. CEO and Director Laura Francis reported a planned sale of 757 shares of common stock at $18.26 per share, executed under a 10b5-1 trading plan, alongside a transfer of shares to a joint revocable trust.

Summary

• Laura Francis, Chief Executive Officer and Director of SI-BONE, Inc. (SIBN), filed a Form 4 detailing changes in her beneficial ownership.
• The filing reports a planned sale of 757 shares of SI-BONE common stock at a price of $18.26 per share.
• The transaction date for the reported sale is July 7, 2025.
• The sale was effected pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction.
• The document also reflects a transfer of shares from Laura Francis to The David & Laura Joint Rev Tr.
• Following the reported transactions, Laura Francis directly owns 431,047 shares of common stock, which includes 418,615 shares issuable upon the settlement of restricted stock units.
• The David & Laura Joint Rev Tr indirectly holds 362,141 shares of SI-BONE common stock.

Sentiment

Score: 5

Explanation: The document reports a pre-planned insider stock sale and a transfer to a trust, which are generally neutral events for market sentiment as they are typically for personal financial planning rather than a reaction to new company performance.

Positives

• The sale of shares by the CEO was conducted pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction for personal financial planning rather than a reaction to new company-specific negative information.

Negatives

• A sale of shares by a Chief Executive Officer, even if pre-planned, reduces their direct ownership stake in the company.

Related Party Transactions

• The transfer of shares from Laura Francis to The David & Laura Joint Rev Tr represents a transaction between the reporting person and a related entity (her revocable trust).

Stakeholder Impact

• Shareholders: The sale of 757 shares represents a very minor reduction in the CEO's direct ownership, which is unlikely to have a significant impact on the overall share structure or market perception, especially given it's a 10b5-1 plan.

Key Dates

Keywords

SI-BONE, SIBN, Form 4, insider trading, stock sale, 10b5-1 plan, beneficial ownership, Laura Francis, CEO, director